Skip to main content
    R

    Rigel Pharmaceuticals Inc (RIGL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $42.92
    -0.81 (-1.85%)

    Market Cap: $823.43M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Rigel Pharmaceuticals Inc (RIGL) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Rigel Pharmaceuticals (RIGL) has a latest price of $42.92 on Nov 17, 2026, 18.4% below its 52-week high of $52.60. Its price rose 2.3% over the past 12 months. The month-end price rose 97.3% over the 10 years through Oct 2026, a compound annual rate of 7.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $51.31 in Oct 2026 and its lowest $6.72 in Nov 2022, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RIGL with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RIGL.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 8.6%, and over 6 months it rose 51.7%. The month-end price rose 535.6% over the 3 years through Oct 2026, a compound annual rate of 85.2%.

    PeriodChange
    1 month-8.1%
    3 months-8.6%
    6 months+51.7%
    12 months+2.3%
    12 months, with dividends+2.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+535.6%+85.2%
    5 years+52.7%+8.8%
    10 years+97.3%+7.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 154.6%, and its weakest was 2022, when it fell 43.4%.

    YearCloseChange
    2026 through Oct 2026$51.31+19.8%
    2025$42.83+154.6%
    2024$16.82+16.0%
    2023$14.50-3.3%
    2022$15.00-43.4%
    2021$26.50-24.3%
    2020$35.00+63.6%
    2019$21.40-7.0%
    2018$23.00-40.7%
    2017$38.80+63.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 9.2% below its 50-day average of $47.25 and 14.0% above its 200-day average of $37.66.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$42.92
    52-week high$52.60-18.4%
    52-week low$24.95+72.0%
    50-day average$47.25-9.2%
    200-day average$37.66+14.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 50.8%.

    MeasureValue
    1-year beta1.08
    Largest fall, 1 year-50.1%
    Largest fall, 3 years-50.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RIGL

    What is RIGL's 1-year price change?

    Rigel Pharmaceuticals's price rose 2.3% over the past 12 months. With dividends included, the 12-month total return was 2.3%.

    What is RIGL's 5-year price change?

    Rigel Pharmaceuticals's month-end price rose 52.7% over the 5 years through Oct 2026, a compound annual rate of 8.8%. These figures leave out dividends.

    What is RIGL's 52-week high and low?

    Rigel Pharmaceuticals's 52-week high is $52.60 and its 52-week low is $24.95. Its latest price of $42.92 on Nov 17, 2026 is 18.4% below the high.

    What is RIGL's beta?

    Rigel Pharmaceuticals's 1-year beta against the S&P 500 is 1.08, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 50.1%.

    Is the RIGL chart free?

    Yes. Advanced Charting for RIGL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.